| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/21/1999 | CN1044235C Sulfonamide endothelin antagonists |
| 07/21/1999 | CN1044234C Substituted phenylimidazolidines, their preparation process, their use as medicaments and the pharmaceutical compositions containing them |
| 07/20/1999 | USRE36256 Administering aryl-substituted quinoxaline derivatives as antiproliferative, anticarcinogenic and antitumor agents |
| 07/20/1999 | US5925782 Synthetic excitatory amino acids |
| 07/20/1999 | US5925780 Viricides for retroviral species |
| 07/20/1999 | US5925776 Low sodium, potassium, and aluminum cation content; storage stability; exposing to cationic exchange resin |
| 07/20/1999 | US5925772 Cysteine protease inhibitors containing heterocyclic leaving groups |
| 07/20/1999 | US5925770 Certain fused pyrrolecarboxanilides; a new class of gaba brain receptor ligands |
| 07/20/1999 | US5925768 Antiinflammatory agents; analgesics, anticoagulants, narcotics |
| 07/20/1999 | US5925744 Macrocyclic compound for sequence cleavage of rna |
| 07/20/1999 | US5925733 DNA polymerase of gamma herpes viruses associated with Kaposi's sarcoma and retroperitoneal fibromatosis |
| 07/20/1999 | US5925729 Isolated amino acid sequence encoding antigen; use as agent for treating the cancer for which the antigen is a ?marker?, as well as in various diagnostic approaches to oncology |
| 07/20/1999 | US5925684 Stable oil in water emulsion containing carotenoid, ethylene oxide-propylene oxide block copolymer emulsifier |
| 07/20/1999 | US5925682 Epinephrine as inhibitor of cancerous tumors |
| 07/20/1999 | US5925680 Synthetic excitatory amino acids |
| 07/20/1999 | US5925679 Glycol base with azelaic acid and acid ph for skin disorders like acne, hair loss and wrinkling |
| 07/20/1999 | US5925678 Use of N-acyl derivatives of aminoalcohols in the manufacture of a medicament for practicing neuroprotective action in neuropathological states connected with excitotoxicity |
| 07/20/1999 | US5925677 Lacrimation accelerating agent |
| 07/20/1999 | US5925672 Administering haloenol lactone to inhibit anandamide amidohydrolase |
| 07/20/1999 | US5925671 Administering to mammals an isocoumarin compound from fermentation of microorganisms like bacillus |
| 07/20/1999 | US5925669 Antitumor agents |
| 07/20/1999 | US5925668 Thioctic metabolites and methods of use thereof |
| 07/20/1999 | US5925667 Pyrrolidine derivative, anti-ulcer drug, and antibacterial drug |
| 07/20/1999 | US5925666 Dopamine uptake inhibitors; drug abuse and dependence, eating disorders, attention deficit disorder, tourette*s syndrome, gambling |
| 07/20/1999 | US5925665 Imidazoline compounds |
| 07/20/1999 | US5925664 Method for treating ocular hypertension and glaucoma |
| 07/20/1999 | US5925663 Benzimidazole derivatives |
| 07/20/1999 | US5925662 Compounds derived from oxazolidin-2-one and preparation and therapeutical use thereof |
| 07/20/1999 | US5925661 Nervous system disorders |
| 07/20/1999 | US5925660 Enzyme inhibitors for phosphatase |
| 07/20/1999 | US5925659 Substituted 4-hydroxamido-2-phenyl-oxazolines for treatment of gramnegative bacterial infections |
| 07/20/1999 | US5925657 Use of PPARγ agonists for inhibition of inflammatory cytokine production |
| 07/20/1999 | US5925654 Antiinflammatory agents and enzyme inhibitors |
| 07/20/1999 | US5925653 Substituted pyridines and pyrimidines processes for their preparation and their use as pesticides and fungicides |
| 07/20/1999 | US5925651 Inhibitors of farnesyl-protein transferase |
| 07/20/1999 | US5925650 Annelated dihydropyridines and the use thereof for preparing pharmaceutical preparations |
| 07/20/1999 | US5925649 Ascomycins |
| 07/20/1999 | US5925647 Treatment of insulin non-insulin dependent diabetes |
| 07/20/1999 | US5925646 Heterocyclic aryl-, alkyl- and cycloalkylacetamides |
| 07/20/1999 | US5925645 Arteriosclerosis |
| 07/20/1999 | US5925643 Treating human immunodeficiency virus infections |
| 07/20/1999 | US5925642 Pyridopyrimidines |
| 07/20/1999 | US5925641 Farnesyltransferase inhibitor |
| 07/20/1999 | US5925640 Carbostyril compounds as antiinflammatory agents and treatment of cardiovascular disorders |
| 07/20/1999 | US5925639 Keto amide derivatives useful as farnesyl protein transferase inhibitors |
| 07/20/1999 | US5925637 Inhibition of matrix metalloproteases by substituted biaryl oxobutyric acids |
| 07/20/1999 | US5925636 Inhibitors of tumor necrosis factor, phosphodiesterase |
| 07/20/1999 | US5925634 Use of ibogaine for treating neuropathic pain |
| 07/20/1999 | US5925633 3-Substituted-4-oxa-1-azabicyclo 3,2,0!heptan-7-one as cysteine protease inhibitors |
| 07/20/1999 | US5925632 Derivatives of 3-pyrrolidylidene-2-one-cephalsporines |
| 07/20/1999 | US5925630 Neuroactive steroids of the androstane and pregnane series |
| 07/20/1999 | US5925629 Sexual dysfunction |
| 07/20/1999 | US5925627 Use of NK-1 receptor antagonists for treating movement disorders |
| 07/20/1999 | US5925626 Hyaluronic acid fractions having pharmaceutical activity, and pharmaceutical compositions containing the same |
| 07/20/1999 | US5925625 Pharmaceutical composition for the intranasal administration of hydroxocobalamin |
| 07/20/1999 | US5925624 Antiinflammatory agents treating patients with inflammatory conditions susceptible to leukocyte-induced tissue damage |
| 07/20/1999 | US5925621 Method for preventing sexually transmitted diseases |
| 07/20/1999 | US5925616 Synergistic mixtures |
| 07/20/1999 | US5925557 This invention relates generally to the field of protein kinases, oncogenes and oncoproteins and, specifically, to a protein kinase which phosphorylates and potentiates the activity of c-fos. |
| 07/20/1999 | US5925379 Removing bile salts from patient by administering interpenetrating polymer network comprising cationic polymer |
| 07/20/1999 | US5925376 Method for treating psoriasis using selected phosphorylase kinase inhibitor and additional compounds |
| 07/20/1999 | US5925375 Therapeutic use of multilamellar liposomal prostaglandin formulations |
| 07/20/1999 | US5925373 Transdermal delivery device containing an estrogen |
| 07/20/1999 | US5925369 Bis alkanoyl esters of carnitine having bactericidal, fungicidal and antiprotozoal activity |
| 07/20/1999 | US5925354 Riboflavin mutants as vaccines against Actinobacillus pleuropneumoniae |
| 07/20/1999 | US5925351 Soluble lymphotoxin-β receptors and anti-lymphotoxin receptor and ligand antibodies as therapeutic agents for the treatment of immunological disease |
| 07/20/1999 | US5925342 Method for reducing intraocular pressure in the mammalian eye by administration of potassium channel blockers |
| 07/20/1999 | US5925334 Administering phospholipid aersol as hyperosmolor compound, mucolytic agent or antisecretory agent |
| 07/20/1999 | US5925333 Screening for compounds that alter the binding by scavengers |
| 07/20/1999 | CA2259699A1 Cyclodextrin compositions |
| 07/20/1999 | CA2256096A1 1-isothiazolidinone derivatives of azetidine-2-one, processes for the preparation thereof and use thereof |
| 07/20/1999 | CA2169460C Oral compositions containing stannous compounds |
| 07/20/1999 | CA2163837C Crystalline paclitaxel hydrates |
| 07/20/1999 | CA2162919C Rectal compositions |
| 07/20/1999 | CA2158036C 3,4-diarylchromans for treatment of dermatitis |
| 07/20/1999 | CA2082394C Pseudomonas exotoxins of low animal toxicity and high cytocidal activity |
| 07/20/1999 | CA2060223C Injectable medical lubricating fluid composition and method of use |
| 07/20/1999 | CA2046361C (6,7-substituted-8-alkoxy-1-cyclopropyl-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid-03,04) bis (acyloxy-0) borate, salts and hydrates thereof |
| 07/20/1999 | CA2024419C Novel bivalent metal salts of n,n-di(carboxymethyl)-2-amino-3-cyano-4-carboxymethyl-5-carboxythiophene acid, process for their preparation and pharmaceutical compositions containing them |
| 07/20/1999 | CA2007200C 2-aminopyrimidinone derivatives |
| 07/20/1999 | CA2001144C Contraception system and method |
| 07/20/1999 | CA1340672C Cephalosporin derivatives |
| 07/20/1999 | CA1340660C Hydrophilic matrix dihydroergotamine (dhe) tablet and process for prducing the same |
| 07/20/1999 | CA1340657C Modulateurs de la proteine kinase c |
| 07/16/1999 | CA2258454A1 Benzosulfone derivatives |
| 07/15/1999 | WO1999035277A2 Recombinant, active caspases and uses thereof |
| 07/15/1999 | WO1999035266A2 Human urotensin ii |
| 07/15/1999 | WO1999035259A1 Identification of lysolipid receptors involved in inflammatory response |
| 07/15/1999 | WO1999035246A1 Novel steroid-activated nuclear receptors and uses therefor |
| 07/15/1999 | WO1999035243A2 Extension of cellular lifespan, methods and reagents |
| 07/15/1999 | WO1999035226A1 Soap bars with a bactericidal capacity and methods of enhancing such capacity |
| 07/15/1999 | WO1999035168A1 Secreted proteins and polynucleotides encoding them |
| 07/15/1999 | WO1999035161A1 Process for preparing carboxamido-4-azasteroids |
| 07/15/1999 | WO1999035158A1 36 human secreted proteins |
| 07/15/1999 | WO1999035157A1 Novel erythromycin derivatives |
| 07/15/1999 | WO1999035156A1 Novel macrolides |
| 07/15/1999 | WO1999035155A1 Novel aromatic amides, preparation method and application as medicines |
| 07/15/1999 | WO1999035153A1 Anthracycline glycosides |
| 07/15/1999 | WO1999035150A1 Synthesis of combretastatin a-4 prodrugs and trans-isomers thereo f |
| 07/15/1999 | WO1999035147A1 Purine derivatives and adenosine a2 receptor antagonists serving as preventives/remedies for diabetes |